182 related articles for article (PubMed ID: 26273818)
21. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA.
Pavlidis P; Shums Z; Koutsoumpas AL; Milo J; Papp M; Umemura T; Lakatos PL; Smyk DS; Bogdanos DP; Forbes A; Norman GL
Clin Chim Acta; 2015 Feb; 441():176-81. PubMed ID: 25512163
[TBL] [Abstract][Full Text] [Related]
23. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
[TBL] [Abstract][Full Text] [Related]
24. Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives.
Demirsoy H; Ozdil K; Ersoy O; Kesici B; Karaca C; Alkim C; Akbayir N; Erdem LK; Onuk MD; Beyzadeoglu HT
World J Gastroenterol; 2010 Dec; 16(45):5732-8. PubMed ID: 21128324
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic anti-GP2 and anti-Saccharomyces cerevisiae antibodies in ruminants with paratuberculosis: A better understanding of the immunopathogenesis of Crohn's disease.
Liaskos C; Gkoutzourelas A; Spyrou V; Koutsoumpas A; Athanasiou LV; Amiridis GS; Billinis C; Bogdanos DP
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):778-785. PubMed ID: 32035824
[TBL] [Abstract][Full Text] [Related]
26. Glycoprotein 2 antibodies in Crohn's disease.
Roggenbuck D; Reinhold D; Werner L; Schierack P; Bogdanos DP; Conrad K
Adv Clin Chem; 2013; 60():187-208. PubMed ID: 23724745
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
Schoepfer AM; Schaffer T; Mueller S; Flogerzi B; Vassella E; Seibold-Schmid B; Seibold F
Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.
Lakatos PL; Altorjay I; Szamosi T; Palatka K; Vitalis Z; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Barta Z; Stocker W; Papp J; Veres G; Papp M;
Inflamm Bowel Dis; 2009 Mar; 15(3):365-74. PubMed ID: 18972554
[TBL] [Abstract][Full Text] [Related]
29. Evidence of Crohn's disease-related anti-glycoprotein 2 antibodies in patients with celiac disease.
Roggenbuck D; Vermeire S; Hoffman I; Reinhold D; Schierack P; Goihl A; von Arnim U; De Hertogh G; Polymeros D; Bogdanos DP; Bossuyt X
Clin Chem Lab Med; 2015 Aug; 53(9):1349-57. PubMed ID: 25411995
[TBL] [Abstract][Full Text] [Related]
30. Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's Disease.
Shpoliansky M; Roggenbuck D; Pinsker M; Salamon N; Weiss B; Shouval DS; Werner L
Dig Dis Sci; 2021 Aug; 66(8):2619-2626. PubMed ID: 32886311
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
32. Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease.
Folwaczny C; Noehl N; Endres SP; Loeschke K; Fricke H
Scand J Gastroenterol; 1998 May; 33(5):523-8. PubMed ID: 9648993
[TBL] [Abstract][Full Text] [Related]
33. Differential diagnosis of Crohn's disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae.
Duman AE; Hülagü S; Çelebi A; Korkmaz U; Musul MM; Şentürk Ö; Şirin G; Yılmaz H; Koç DÖ; Dindar G; Öztürkler M; Bozkurt N; Kır HM
Turk J Gastroenterol; 2019 Jan; 30(1):21-27. PubMed ID: 30465525
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory Bowel Disease-associated GP2 Autoantibodies Inhibit Mucosal Immune Response to Adherent-invasive Bacteria.
Derer S; Brethack AK; Pietsch C; Jendrek ST; Nitzsche T; Bokemeyer A; Hov JR; Schäffler H; Bettenworth D; Grassl GA; Sina C
Inflamm Bowel Dis; 2020 Nov; 26(12):1856-1868. PubMed ID: 32304568
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic autoantibodies in inflammatory bowel disease.
Joossens S; Vermeire S; Van Steen K; Godefridis G; Claessens G; Pierik M; Vlietinck R; Aerts R; Rutgeerts P; Bossuyt X
Inflamm Bowel Dis; 2004 Nov; 10(6):771-7. PubMed ID: 15626896
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic autoantibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Drygiannakis D; Karmiris K; Drygiannakis I; Makreas S; Kouroumalis EA
Dig Dis Sci; 2005 Dec; 50(12):2330-4. PubMed ID: 16416183
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease.
Kovacs M; Lakatos PL; Papp M; Jacobsen S; Nemes E; Polgar M; Solyom E; Bodi P; Horvath A; Muller KE; Molnar K; Szabo D; Cseh A; Dezsofi A; Arato A; Veres G
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):429-35. PubMed ID: 22465933
[TBL] [Abstract][Full Text] [Related]
38. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B
Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574
[TBL] [Abstract][Full Text] [Related]
39. Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challenges.
Roggenbuck D; Reinhold D; Schierack P; Bogdanos DP; Conrad K; Laass MW
Clin Chem Lab Med; 2014 Apr; 52(4):483-94. PubMed ID: 24231127
[TBL] [Abstract][Full Text] [Related]
40. Autoimmunity in Crohn's Disease-A Putative Stratification Factor of the Clinical Phenotype.
Roggenbuck D; Reinhold D; Baumgart DC; Schierack P; Conrad K; Laass MW
Adv Clin Chem; 2016; 77():77-101. PubMed ID: 27717419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]